What is Virta?
Virta Health offers a novel approach to managing type 2 diabetes, focusing on medication-free and non-surgical treatment protocols. Their remote care platform delivers comprehensive medical and behavioral support, aiming for not just diabetes reversal but also sustained improvements in broader metabolic and cardiovascular health markers, including blood pressure, inflammation, BMI, and liver function. This data-driven, patient-centric model positions Virta at the forefront of chronic disease management innovation.
How much funding has Virta raised?
Virta has raised a total of $403.8M across 7 funding rounds:
Private Equity
$28.8M
Series A
$37M
Series B
$45M
Multiple Rounds
$160M
Series E
$133M
Private Equity (2016): $28.8M, investors not publicly disclosed
Series A (2017): $37M led by Venrock
Series B (2018): $45M supported by Venrock, The Obvious, Founders Fund, Playground Global, Creandum, Caffeinated Capital, and SciFi VC
Series C (2020): $93M featuring Creandum, Caffeinated Capital, Venrock, SciFi VC, Playground Global, and The Obvious
Debt (2020): $2M backed by PPP
Series D (2020): $65M with participation from Sequoia Capital Global Equities
Series E (2021): $133M led by Tiger Global
Key Investors in Virta
Tiger Global
Tiger Global is an independent contract manufacturing and sourcing group based in the United Kingdom, known for its involvement in various industrial sectors.
Venrock
Venrock, a venture capital firm founded in 1969 and headquartered in Palo Alto, California, is recognized for its long track record of backing successful technology and healthcare ventures, offering strategic guidance and deep industry expertise.
Creandum
Creandum is a prominent European venture capital firm that has supported numerous successful technology companies, including Spotify and Klarna, providing investment and advisory services from its bases in Guernsey and Sweden.
What's next for Virta?
The substantial capital infusion, particularly the recent major strategic investment, positions Virta for accelerated scaling and further development of its remote care technology. This funding will likely fuel expansion into new markets, enhance its platform capabilities, and deepen its clinical research to validate and broaden the impact of its treatment model. Virta's trajectory suggests a strong focus on solidifying its leadership in the digital therapeutics space for chronic conditions.
See full Virta company page
